211 related articles for article (PubMed ID: 33445154)
1. A perspective on medicinal chemistry approaches towards adenomatous polyposis coli and Wnt signal based colorectal cancer inhibitors.
Phull MS; Jadav SS; Gundla R; Mainkar PS
Eur J Med Chem; 2021 Feb; 212():113149. PubMed ID: 33445154
[TBL] [Abstract][Full Text] [Related]
2. Adenomatous polyposis coli (APC) membrane recruitment 3, a member of the APC membrane recruitment family of APC-binding proteins, is a positive regulator of Wnt-β-catenin signalling.
Brauburger K; Akyildiz S; Ruppert JG; Graeb M; Bernkopf DB; Hadjihannas MV; Behrens J
FEBS J; 2014 Feb; 281(3):787-801. PubMed ID: 24251807
[TBL] [Abstract][Full Text] [Related]
3. miR-155 Is Downregulated in Familial Adenomatous Polyposis and Modulates WNT Signaling by Targeting AXIN1 and TCF4.
Prossomariti A; Piazzi G; D'Angelo L; Miccoli S; Turchetti D; Alquati C; Montagna C; Bazzoli F; Ricciardiello L
Mol Cancer Res; 2018 Dec; 16(12):1965-1976. PubMed ID: 30072583
[TBL] [Abstract][Full Text] [Related]
4. Differences in the localization of the adenomatous polyposis coli-Asef/Asef2 complex between adenomatous polyposis coli wild-type and mutant cells.
Kawasaki Y; Furukawa S; Sato R; Akiyama T
Cancer Sci; 2013 Aug; 104(8):1135-8. PubMed ID: 23910005
[TBL] [Abstract][Full Text] [Related]
5. C644-0303, a small-molecule inhibitor of the Wnt/β-catenin pathway, suppresses colorectal cancer growth.
Yan Y; Zhang Y; Li M; Zhang Y; Zhang X; Zhang X; Xu Y; Wei W; Wang J; Xu X; Song Q; Zhao C
Cancer Sci; 2021 Nov; 112(11):4722-4735. PubMed ID: 34431598
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-494 promotes cancer progression and targets adenomatous polyposis coli in colorectal cancer.
Zhang Y; Guo L; Li Y; Feng GH; Teng F; Li W; Zhou Q
Mol Cancer; 2018 Jan; 17(1):1. PubMed ID: 29304823
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic potential of targeting the Wnt/β-catenin signaling pathway in colorectal cancer.
Cheng X; Xu X; Chen D; Zhao F; Wang W
Biomed Pharmacother; 2019 Feb; 110():473-481. PubMed ID: 30530050
[TBL] [Abstract][Full Text] [Related]
8. The effect of a germline mutation in the APC gene on β-catenin in human embryonic stem cells.
Yedid N; Kalma Y; Malcov M; Amit A; Kariv R; Caspi M; Rosin-Arbesfeld R; Ben-Yosef D
BMC Cancer; 2016 Dec; 16(1):952. PubMed ID: 28010732
[TBL] [Abstract][Full Text] [Related]
9. Smad4-mediated signaling inhibits intestinal neoplasia by inhibiting expression of β-catenin.
Freeman TJ; Smith JJ; Chen X; Washington MK; Roland JT; Means AL; Eschrich SA; Yeatman TJ; Deane NG; Beauchamp RD
Gastroenterology; 2012 Mar; 142(3):562-571.e2. PubMed ID: 22115830
[TBL] [Abstract][Full Text] [Related]
10. Adenomatous Polyposis Coli as a Major Regulator of Human Embryonic Stem Cells Self-Renewal.
Preisler L; Ben-Yosef D; Mayshar Y
Stem Cells; 2019 Dec; 37(12):1505-1515. PubMed ID: 31461190
[TBL] [Abstract][Full Text] [Related]
11. Design and Synthesis of TASIN Analogues Specifically Targeting Colorectal Cancer Cell Lines with Mutant Adenomatous Polyposis Coli (APC).
Wang W; Zhang L; Morlock L; Williams NS; Shay JW; De Brabander JK
J Med Chem; 2019 May; 62(10):5217-5241. PubMed ID: 31070915
[TBL] [Abstract][Full Text] [Related]
12. Peptidomimetic inhibitors of APC-Asef interaction block colorectal cancer migration.
Jiang H; Deng R; Yang X; Shang J; Lu S; Zhao Y; Song K; Liu X; Zhang Q; Chen Y; Chinn YE; Wu G; Li J; Chen G; Yu J; Zhang J
Nat Chem Biol; 2017 Sep; 13(9):994-1001. PubMed ID: 28759015
[TBL] [Abstract][Full Text] [Related]
13. Rapamycin inhibition of polyposis and progression to dysplasia in a mouse model.
Hardiman KM; Liu J; Feng Y; Greenson JK; Fearon ER
PLoS One; 2014; 9(4):e96023. PubMed ID: 24763434
[TBL] [Abstract][Full Text] [Related]
14. Targeting the Wnt signaling pathway in colorectal cancer.
Sawa M; Masuda M; Yamada T
Expert Opin Ther Targets; 2016; 20(4):419-29. PubMed ID: 26439805
[TBL] [Abstract][Full Text] [Related]
15. Berberine potently attenuates intestinal polyps growth in ApcMin mice and familial adenomatous polyposis patients through inhibition of Wnt signalling.
Zhang J; Cao H; Zhang B; Cao H; Xu X; Ruan H; Yi T; Tan L; Qu R; Song G; Wang B; Hu T
J Cell Mol Med; 2013 Nov; 17(11):1484-93. PubMed ID: 24015932
[TBL] [Abstract][Full Text] [Related]
16. Different APC genotypes in proximal and distal sporadic colorectal cancers suggest distinct WNT/β-catenin signalling thresholds for tumourigenesis.
Christie M; Jorissen RN; Mouradov D; Sakthianandeswaren A; Li S; Day F; Tsui C; Lipton L; Desai J; Jones IT; McLaughlin S; Ward RL; Hawkins NJ; Ruszkiewicz AR; Moore J; Burgess AW; Busam D; Zhao Q; Strausberg RL; Simpson AJ; Tomlinson IP; Gibbs P; Sieber OM
Oncogene; 2013 Sep; 32(39):4675-82. PubMed ID: 23085758
[TBL] [Abstract][Full Text] [Related]
17. [Familial adenomatous polyposis syndrome (FAP): pathogenesis and molecular mechanisms].
Friedrich A; Kullmann F
Med Klin (Munich); 2003 Dec; 98(12):776-82. PubMed ID: 14685680
[TBL] [Abstract][Full Text] [Related]
18. APC mutations in human colon lead to decreased neuroendocrine maturation of ALDH+ stem cells that alters GLP-2 and SST feedback signaling: Clue to a link between WNT and retinoic acid signalling in colon cancer development.
Zhang T; Ahn K; Emerick B; Modarai SR; Opdenaker LM; Palazzo J; Schleiniger G; Fields JZ; Boman BM
PLoS One; 2020; 15(10):e0239601. PubMed ID: 33112876
[TBL] [Abstract][Full Text] [Related]
19. New perspectives on APC control of cell fate and proliferation in colorectal cancer.
Phelps RA; Broadbent TJ; Stafforini DM; Jones DA
Cell Cycle; 2009 Aug; 8(16):2549-56. PubMed ID: 19597346
[TBL] [Abstract][Full Text] [Related]
20. Cross-species comparison of human and mouse intestinal polyps reveals conserved mechanisms in adenomatous polyposis coli (APC)-driven tumorigenesis.
Gaspar C; Cardoso J; Franken P; Molenaar L; Morreau H; Möslein G; Sampson J; Boer JM; de Menezes RX; Fodde R
Am J Pathol; 2008 May; 172(5):1363-80. PubMed ID: 18403596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
